LZTS2

gene product
KIAA1813, LAPSER1
The protein encoded by this gene belongs to the leucine zipper tumor suppressor family of proteins, which function in transcription regulation and cell cycle control. This family member can repress beta-catenin-mediated transcriptional activation and is a negative regulator of the Wnt signaling pathway. It negatively regulates microtubule severing at centrosomes, and is necessary for central spindle formation and cytokinesis completion. It is implicated in cancer, where it may inhibit cell proliferation and decrease susceptibility to tumor development. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Dec 2015]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
153 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
GeneTex
4 antibodies
Boster Biological Technology
3 antibodies
antibodies-online
50 antibodies
Invitrogen Antibodies
4 antibodies
LifeSpan BioSciences, Inc.
24 antibodies
OriGene
4 antibodies
Atlas Antibodies
1 antibody
Novus Biologicals
5 antibodies
Abgent
4 antibodies
ProSci
2 antibodies
NovoPro Bioscience Inc.
1 antibody
Acris Antibodies GmbH
3 antibodies
Abnova Corporation
4 antibodies
Biorbyt
10 antibodies
Aviva Systems Biology
2 antibodies
Rockland Immunochemicals, Inc.
2 antibodies
MyBioSource
2 antibodies
Creative Diagnostics
5 antibodies
Bethyl Laboratories
1 antibody
St John's Laboratory
1 antibody
MilliporeSigma / Merck KGaA
3 antibodies
United States Biological
14 antibodies
RayBiotech, Inc.
1 antibody
Abbexa
1 antibody
Creative Biolabs
1 antibody